MarketCap
Facebook
X
Telegram
Castle Biosciences EV/EBITDA Ratio | CSTL
Annual EV/EBITDA Ratio Castle Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -227 | 27 | -11.1 | -9.4 | -21.8 | -142 | 24 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27 | -227 | -51.4 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M |  USA |
 |
ICON Public Limited Company
ICLR
|
20 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
0.0391 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.84 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.303 | $ 2.37 | 15.05 % | $ 9.44 M |  Israel |
 |
Myriad Genetics
MYGN
|
-1.79 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.785 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
-1.27 | $ 50.52 | -0.07 % | $ 11 B |  Niderland |
 |
NeoGenomics
NEO
|
-23.2 | $ 16.97 | -3.58 % | $ 2.17 B | USA |
 |
OPKO Health
OPK
|
-51.8 | $ 1.71 | 0.58 % | $ 1.28 B | USA |
 |
Pacific Biosciences of California
PACB
|
-2.24 | $ 2.22 | -5.93 % | $ 666 M | USA |
 |
Neogen Corporation
NEOG
|
37.8 | $ 11.67 | -3.44 % | $ 2.54 B | USA |
 |
Precipio
PRPO
|
988 | $ 23.56 | 6.13 % | $ 37.8 M | USA |
 |
Personalis
PSNL
|
-4.87 | $ 15.9 | -0.31 % | $ 1.42 B | USA |
 |
Sotera Health Company
SHC
|
74.5 | $ 16.25 | -1.16 % | $ 4.61 B | USA |
 |
Quidel Corporation
QDEL
|
9.16 | $ 11.56 | -4.43 % | $ 487 M | USA |
 |
Centogene N.V.
CNTG
|
0.283 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Trinity Biotech plc
TRIB
|
-15.5 | $ 5.88 | 10.08 % | $ 2.11 B | Irlanda |
 |
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | China |
 |
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
-270 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
14.3 | $ 26.91 | 0.9 % | $ 602 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-13.9 | $ 132.17 | -2.35 % | $ 7.9 B | USA |
 |
Organovo Holdings
ONVO
|
-0.307 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.234 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
5.25 | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
60.2 | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-6.55 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-32.4 | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
15.5 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
24.9 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
26.6 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
627 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
26.6 | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
17.1 | $ 30.39 | -1.32 % | $ 28.8 B | Niderland |
 |
RadNet
RDNT
|
33.9 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-5.62 | $ 10.05 | 2.55 % | $ 419 M | USA |
 |
Neuronetics
STIM
|
-6.02 | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
-1.13 | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
21.2 | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-38.2 | $ 155.43 | -2.12 % | $ 19.5 B | USA |